Clearstead Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$138 Sell
23
-62
-73% -$467 ﹤0.01% 981
2025
Q4
$610 Sell
85
-43
-34% -$340 ﹤0.01% 974
2025
Q3
$1.37K Sell
128
-633
-83% -$6.21K ﹤0.01% 1122
2025
Q2
$7.37K Buy
761
+553
+266% +$5.7K ﹤0.01% 661
2025
Q1
$3.1K Buy
208
+170
+447% +$2.61K ﹤0.01% 704
2024
Q4
$567 Buy
38
+23
+153% +$375 ﹤0.01% 428
2024
Q3
$287 Hold
15
﹤0.01% 412
2024
Q2
$311 Hold
15
﹤0.01% 430
2024
Q1
$282 Sell
15
-17
-53% -$292 ﹤0.01% 424
2023
Q4
$462 Sell
32
-103
-76% -$1.4K ﹤0.01% 408
2023
Q3
$2.34K Hold
135
﹤0.01% 409
2023
Q2
$2.81K Sell
135
-14
-9% -$304 ﹤0.01% 351
2023
Q1
$3.5K Sell
149
-273
-65% -$7.33K ﹤0.01% 330
2022
Q4
$12K Sell
422
-268
-39% -$6.85K ﹤0.01% 302
2022
Q3
$16K Buy
+690
New +$20.8K 0.01% 268

Other funds holding OGN

Clearstead Trust's OGN Position: Q1 2026 in Review

Clearstead Trust reduced its Organon & Co (OGN) stake by 73% in Q1 2026, selling an estimated $467 and leaving 23 shares worth $138. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Clearstead Trust first reported a position in OGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $16K in Q3 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Clearstead Trust held 23 shares of Organon & Co worth $138 as of Q1 2026.
  • Clearstead Trust sold 62 Organon & Co shares in Q1 2026, an estimated $467.
  • Organon & Co made up ﹤0.01% of Clearstead Trust's portfolio in Q1 2026, its #981 holding.
  • Clearstead Trust first reported a position in Organon & Co in Q3 2022 and has held it in 15 quarters since.
  • Clearstead Trust's Organon & Co position peaked at $16K in Q3 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.